Administration of recombinant FVIIa (rFVIIa) to concizumab-dosed monkeys is safe, and concizumab does not affect the potency of rFVIIa in hemophilic rabbits - Lauritzen, B; Olling, J; Abel, K L (J Thromb Haemost, 2019)